The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon α (IFN α) or interferon γ (IFN γ) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 161-168

  Robak, Tadeusz ^a   Korycka, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

2 chlorodeoxyadenosine; Acute myeloid leukemia; Chronic myeloid leukemia; Cultures in vitro; Interferon ; Interferon

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; RECOMBINANT GAMMA INTERFERON;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CELL CULTURE; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CLADRIBINE; DRUG SYNERGISM; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA, RECOMBINANT; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MACROPHAGES; MIDDLE AGED; TUMOR STEM CELLS;

EID: 0030021556     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067594     Document Type: Review

References (34)

1. Piro, L. D. (1992) 2-chlorodeoxyadenosine treatment of lymphoid malignancies. Blood, 80, 843-845.
2. Lauria, F. (1992) 2-Chlorodeoxyadenosine. "novel" agent in the treatment of both lymphoid and myeloid malignancies. Haematologica, 77, 443-445.
3. Santana, V. M., Mirro, Jr. J., Kearns, C., Schell, M. J. and Crom, W. (1992) Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J. Clin. Oncol., 10, 364-370.
4. Saven, A., Lemon, R., Figueroa, M., Kosty, M. and Ellison, D. (1993) Complete hematologic remissions in stable phase. Ph - chromosome positive, chronic myeloid leukemia (CML) following 2-chlorodeoxyadenosine (2-CdA). Proc. Am. Soc. Clin. Oncol., p. 310 (Abst. No 1022).
5. Goldstein, D. and Laszlo, J. (1986) Interferon in cancer: From imagination to inrferon. Cancer Res., 46, 4315-4329.
6. Wadler, S. and Schwartz, E. L. (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies. A review. Cancer Res., 50, 3473-3486.
7. Dvilansky, A., Kafka, M. and Nathan, J. (1992) Mechanisms of interaction between interferon gamma and antineoplastic agents on growth and differentiation of leukemic cells: a review. Leuk. Lymph., 6, 469-477.
8. Robak, T., Korycka, A. and Góra-Tybor, J. (1994) The interaction of 2-chlorodeoxydenosine (2-CdA) and interferon α (IFNα) on normal and myeloid leukemia hematopoiesis in vitro. Leuk. Res., 18, 275-281.
9. Iscove, N. N., Sieber, F. and Winterhalter, K. H. (1974) Erythroid colony formation in culture of mouse and human bone marrow. Analysis of the requirement chromatography on agarose-can-canavalin A. Am. J. Cell. Physiol., 83, 303-320.
10. Hibbin, J. A., Nioku, O. S., Matutes, E., Lewis, S. M. and Goldman, J. M. (1984) Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders Br. J. Haematol., 57, 495-503.
11. Buick, R. N., Till, J. E. and McCulloch, E. A. (1977) Colony assay for proliferative blast cells circulation in myeloid leukemia. Lancet, 1, 862-863.
12. Korycka, A. and Robak, T. (1991) The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukemic blasts (CFU-L) in the cultures in vitro. Arch. Immunol. Ther. Exp., 39, 495-500.
13. Minden, M. D., Buick, R. N. and McCulloch, E. A. (1979) Separation of blast cells and T-lymphocyte progenitors in the blood of patients with acute myeloid leukemia. Blood, 54, 186-195.
14. Kazimierczuk, Z., Vilpo, J., Hildebrand, C. and Wright, G. (1990) Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6-disubstitutes purines. J. Med. Chem., 33, 1683-1687.
15. Kristensen, J., Nygren, P., Liliemark, J., Fridborg, H., Kiliander, A., Simonsson, B., Oberg, G. and Larsson, R. (1994) Interactions between Cladribine (2-CdA) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myeloid leukemia. Leukemia, 8, 1712-1717.
16. Kurzrock, R., Talpaz, M., Kantarjian, H., Walters, R., Saks, S., Trujillo, J. M. and Gutterman, J. U. (1987) Therapy of chronic myeloid leukemia with recombinant interferon-γ Blood, 70, 943-947.
17. Mahmoud, H. H., Pui, G. H., Kennedy, W., Saffe, H. S., Crist, W. M. and Murphy, S. B. (1992) Phase I study of recombinant human interferon gamma in children with relapsed acute leukemia. Leukemia, 6, 1181-1184.
18. Petzer, A. L., Bilgeri, R., Zihan, U., Hann, M., Geisen, F. H., Pragnell, J., Bransteiner, H. and Konwalinka, G. (1991) Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid and T-lymphocytic colony growth. Blood, 78, 2583-2587.
19. Bryson, H. M. and Sorkin, E. M. (1993) Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in hematological malignancies. Drugs, 46, 872-894.
20. Nara, N. (1993) Combined effect of interferon-γ and tumor necrosis factor-α causing suppression of leukemic blast progenitors in acute myeloid leukemia. Leuk. Lymph., 10, 201-207.
21. Koike, K., Ma, F., Shiohara, M., Kubo, T., Takagi, M., Amano, Y., Nakahata, T. and Komiyama, A. (1992) Interferon gamma inhibits proliferation but not commitment of murine graulocyte-macrophage progenitors. J. Cell. Physiol., 153, 528-533.
22. Shiohara, M., Koike, K. and Nakahata, T. (1993) Synergism of interferon-γ and stem cell factor on the development of murine hematopoietic progenitors in serum free culture. Blood, 81, 1435-1441.
23. Mamus, S. W., Beck-Schroder, S. and Zanjani, E. D. (1985) Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T-lymphocytes. J. Clin. Invest., 75, 1496-1503.
24. Delforge, A., Vandenplas, B., Lagneaux, L., Loos, M., Bron, D., Debusscher, L. and Strykmans, P. (1990) Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid leukemic progenitors. Eur. J. Haematol., 44, 307-311.
25. Todd, P. A. and Goa, K. L. (1992) Interferon-γ-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease. Drugs, 43, 111-122.
26. Morikawa, K., Fan, D., Denkins, Y. M., Lewis, B., Gutterman, J. U., Walker, S. M. and Fidler, I. J. (1989) Mechanism of combined effects of γ-interferon and 5-fluorouracil on human colon cancer implanted into nude mice. Cancer Res., 49, 799-805.
27. Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N. and Lejeune, F. J. (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of limbs melanoma and sarcoma. J. Clin. Oncol., 10, 52-60.
28. Kafka, M., Nathan, J. and Dvilansky, A. (1989) New combination of 5-Fluorouracil and interferon-γ effective against human myeloid leukemia in vitro. Anticancer Res., 9, 1037-1040.
29. Kafka, M., Dvilansky, A. and Nathan, J. (1990) Mechanism of interaction between interferon-γ and antineoplastic agents on the differentiation of HL-60 promyelocyte cells. Exp. Hematol., 18, 153-158.
30. Robertson, L. E., Chubb, S., Meyn, R. E., Stoy, M., Ford, R., Hittelman, W. N. and Plunket, W. (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′deoxyadenosine and 9 - D-arabinosyl-2-fluoroadenine. Blood, 81, 143-150.
31. Faltynek, C. R. (1988) Opposite effects of recombinant interferon - α and deoxycoformycin on adenosine deaminase in the Dandi B lymphoblastoid cell line. Blood, 71, 59-64.
32. Carlo-Stella, C., Cazzola, M., Ganser, A., Bergamachi, G., Pedrazzoli, P., Hoelzer, D. and Ascari, E. (1988) Synergistic antiproliferative effect of recombinant interferon-γ with recombinant interferon-α on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E and CFU-E). Blood, 73, 1293-1299.
33. Ishii, Y. and Tsukagoshi, S. (1989) The synergistic effect of human recombinant interferon alpha 2a in combination with interferon gamma and the induction of interferon alpha 2a receptor by interferon gamma. J. Pharmacobiodyn., 12, 299-304.
34. Wandl, U. B., Ogalka, B., Kloke, O., Nagel-Hiemke, M., Moritz, T. and Niederle, N. (1992) Treatment of chronic myelogenous leukemia with different cytokines. Semin. Oncol., 19, (Supp. 4), 80-86.